| Bio |
Stage IV from initial diagnosis in Aug 2005. Tried everything until finally landing on Phase III trial – MDX-010 – for Ipilimumab and getting accepted under compassionate use (2008). NED since 2009. 2 years of side effects thru 2011. Still here in 2025!
|
